Skip to main content

Table 1 SLE patients and healthy controls characteristics

From: Soluble receptor activator of nuclear factor κB ligand/osteoprotegerin ratio is increased in systemic lupus erythematosus patients

 

SLE patients

Healthy controls

P-value

n

103

114

-

Age, years

44.9 ± 14.1

47.4 ± 13.5

0.182

BMI, Kg/m2

26.6 ± 4.9

26.8 ± 4.9

0.689

Current smokers, n (%)

14 (15.6%)

23 (22.1%)

0.246

Alcohol intake, n (%)

4 (3.9%)

4 (3.6%)

0.602

Postmenopausal, n (%)

44 (49.4%)

57 (53.3%)

0.593

Arterial hypertension, n (%)

52 (50.5%)

47 (42.7%)

0.257

Hyperlipidemia, n (%)

66 (64.1%)

66 (60.6%)

0.596

Diabetes mellitus, n (%)

5 (4.9%)

8 (7.2%)

0.472

  1. Values represent mean ± standard deviation or frequencies of the individuals that presented the characteristic. Differences were assessed using T-test for continuous variables or χ2 or Fisher's exact test for proportions.
  2. BMI, body mass index; SLE, Systemic Lupus Erythematosus